BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Francesco Granata, M.D. Joins Board Of Prismic Pharmaceuticals, Inc.


12/3/2013 10:04:12 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SCOTTSDALE, Ariz., Dec. 3, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, commercial-stage pharmaceutical company focused on prescription Medical Foods, today announced the election of Francesco Granata, M.D., to its Board of Directors.

Dr. Granata is currently Executive in Residence at Warburg Pincus, a leading private equity firm focused on growth investing. He is an accomplished healthcare executive with more than 35 years of experience in the international pharmaceutical and biotechnology industries. Before joining Warburg Pincus, Dr. Granata held senior management positions at Pfizer, where he was President of the Northern Europe region; Schering-Plough, where he served as Group Vice President and President for the Europe and Canada region; and most recently at Biogen Idec Inc., where he was Executive Vice President of Global Commercial Operations, with responsibility for worldwide Commercial Operations and Medical Affairs. Dr. Granata is also a Board Member of Circassia, a UK-based specialty Biopharmaceutical company and Italfarmaco, one of Italy's leading international pharmaceutical groups.

"Francesco Granata has had an exceptionally successful career and brings a wealth of healthcare experience and strategic vision to our Board of Directors," commented Peter Moriarty, Chairman and CEO of Prismic. "Prior to joining the pharmaceutical industry, Francesco practiced as a physician and surgeon, specializing in Cardiology. He has also been Chairman of the European Committee of the Pharmaceutical Research and Manufacturers Association of America and Co-Chairman of the Heads of Europe Committee of the European Federation of Pharmaceutical Industries and Associations. We are honored that he has accepted the invitation to join our Board. We are confident of the contribution he will make in helping the Board to guide Prismic's continuing path to commercial success and increased value for our shareholders."

"Prismic has an extremely interesting and innovative portfolio of patent-protected products," stated Dr. Granata. "I believe that the company has identified products and market opportunities that are medically important as well as commercially very attractive. Prismic has the choice of exploiting those opportunities alone or in partnership with other commercial entities in the United States and Internationally. I look forward to working with my fellow Board members to help Management drive optimum value for our shareholders."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held, commercial-stage pharmaceutical company focused on the development and marketing of prescription Medical Foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved. The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com.

INFORMATION CONTACT
Peter Moriarty
Tel: 480.422.1810

SOURCE Prismic Pharmaceuticals, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES